Sirolimus-Elutin<u>g</u> versus Bare-Metal Low-Profile Stent for <u>R</u>enal <u>A</u>rtery <u>T</u>reatment (GREAT Trial): Angiographic Follow-up after 6 Months and Clinical Outcome up to 2 Years

Abstract

The angiographic outcome at 6 months did not show a significant difference between BMS and SES. Renal artery stenting with both stents significantly improved blood pressure. Future studies with a larger patient population and longer angiographic follow-up are warranted to determine if there is a significant benefit of drug-eluting stents in treating ostial renal artery stenosis.